| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lexaria Bioscience Corp. | Chief Executive Officer, Director | Stock Options | 350K | $305K | $0.87 | 29 Jul 2025 | Direct |
| Lexaria Bioscience Corp. | Chief Executive Officer, Director | common shares | 65K | $59.1K | $0.91 | 29 Jul 2025 | Direct |
| INVIVO THERAPEUTICS HOLDINGS CORP. | Chief Financial Officer | Stock Option (right to buy) | 20.8K | 17 Nov 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LEXX | Lexaria Bioscience Corp. | 29 Jul 2025 | 1 | $13.6K | 4 | Chief Executive Officer, Director | 30 Jul 2025, 11:14 |
| LEXX | Lexaria Bioscience Corp. | 15 May 2025 | 1 | $0 | 4 | Chief Executive Officer, Director | 16 May 2025, 17:47 |
| LEXX | Lexaria Bioscience Corp. | 02 Dec 2024 | 2 | $118K | 4 | Chief Executive Officer | 03 Dec 2024, 14:03 |
| LEXX | Lexaria Bioscience Corp. | 31 Aug 2024 | 0 | $0 | 3 | Chief Executive Officer | 05 Sep 2024, 13:09 |
| NVIV | INVIVO THERAPEUTICS HOLDINGS CORP. | 17 Nov 2022 | 1 | $0 | 4 | Chief Financial Officer | 21 Nov 2022, 16:05 |